What is a Plaque Psoriasis?
Plaque psoriasis is a chronic autoimmune skin disease characterized by the rapid buildup of skin cells, resulting in thick, raised, red patches covered with silvery-white …
Continue Reading
What is a Hyperparathyroidism?
Hyperparathyroidism is a condition in which one or more of the parathyroid glands produce too much parathyroid hormone (PTH). The four small parathyroid glands are …
What is a Central Nervous System?
The Central Nervous System (CNS) consists of the brain and spinal cord, which serve as the body’s main control center. The CNS receives, processes, and …
What is Lysosomal Storage Disorders?
A Lysosomal Storage Disorder (LSD) is a group of rare inherited genetic diseases caused by the deficiency or absence of specific lysosomal enzymes. Lysosomes are …
What is MEK Inhibitor?
A MEK inhibitor is a type of targeted cancer medicine that blocks the activity of MEK proteins (Mitogen-Activated Protein Kinase Kinase 1 and 2), which …
What is Thromboembolic Disorder?
A Thromboembolic Disorder is a condition in which a blood clot (thrombus) forms inside a blood vessel and may partially or completely block blood flow. …
Is Generic Olaparib Available? Biosimilar Myths and Real Cost Outlook
If you or someone you love has been prescribed Olaparib (sold under the brand name Lynparza), you’ve probably already felt the sticker shock. It’s one …
Olaparib Tablets vs Capsules: Key Formulation Differences Explained
Olaparib (Lynparza®) is available as both a tablet and a capsule and a surprisingly common assumption among patients, caregivers, and even some dispensing pharmacists is …
Olaparib vs Niraparib vs Rucaparib: Which PARP Inhibitor Is Right for the Patient?
Disclaimer: This article is for informational purposes only. Always consult a qualified oncologist or clinical pharmacist before making any treatment decisions. This content has been …
How Olaparib Works as a PARP Inhibitor: Full Guide
A cancer diagnosis comes with a long list of unfamiliar words, and “PARP inhibitor” is often one of the most confusing. Your oncologist mentions Olaparib, …